Within this free webinar, Ángel Puente (LCA expert at nova-Institute) will give an inside into the ISO-certified Life Cycle Assessment (LCA) of PEF (polyethylene furanoate) bottles performed in 2022. The presentation and Q&A session will take place online on 22 June 2023, 10:00–11:00 CET. The registration link can be found below.
The PEFerence consortium aims to replace a significant share of fossil-based polyesters, such as polyethylene terephthalate (PET), and packaging materials like glass and metal with 100 % bio-based furanics polyesters. PEFerence establishes a unique, industrial scale, cost-effective flagship plant to convert plant-based sugars into FDCA (furandicarboxylic acid), the building block of PEF (polyethylene furanoate): a plant-based, fully recyclable plastic material with superior performance and significantly reduced carbon footprint compared to conventional plastics. PEF can be used in a wide range of applications such as bottles, packaging, films, fibres and textiles.
The chemical technology company Avantium (NL) partnered with nova-Institut GmbH under the framework of the PEFerence project, to perform a full cradle-to-grave Life Cycle Assessment (LCA) for the YXY® Technology, assessing the potential environmental impacts of PEF packaging solutions in comparison to conventional PET packaging. The LCA was performed according to the ISO 14040/44 standard methodology. A critical peer review of the study, including experts in incumbent technologies, was conducted in order to verify whether the LCA met the requirements for methodology, data, interpretation, and reporting. Within this webinar, Ángel Puente will give an inside into the performance of the LCA and the main aspects of the environmental sustainability of PEF-based bottles. Afterwards, Ingrid Goumans, Team Leader Technical Application Managers at Avantium, and Ángel Puente will answer live questions from the audience.
The registration link and more information about the PEFerence project can be found at www.peference.eu
PEFerence receives funding from the Bio-based Industries Joint Undertaking (JU) under the European Union’s Horizon 2020 research and innovation programme under grant agreement No 744409. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and the Bio-based Industries Consortium.